Current Pain and Headache Reports

, Volume 10, Issue 5, pp 345–349 | Cite as

Treatment of myofascial pain syndrome

  • Chang-Zern HongEmail author


Myofascial pain syndrome (MPS) is caused by myofascial trigger points (MTrPs) located within taut bands of skeletal muscle fibers. Treating the underlying etiologic lesion responsible for MTrP activation is the most important strategy in MPS therapy. If the underlying pathology is not given the appropriate treatment, the MTrP cannot be completely and permanently inactivated. Treatment of active MTrPs may be necessary in situations in which active MTrPs persist even after the underlying etiologic lesion has been treated appropriately. When treating the active MTrPs or their underlying pathology, conservative treatment should be given before aggressive therapy. Effective MTrP therapies include manual therapies, physical therapy modalities, dry needling, or MTrP injection. It is also important to eliminate any perpetuating factors and provide adequate education and home programs to patients so that recurrent or chronic pain can be avoided.


Botulinum Toxin Trigger Point Myofascial Pain Myofascial Pain Syndrome Myofascial Trigger Point 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Hong CZ, Simons DG: Pathophysiologic and electrophysiologic mechanism of myofascial trigger points. Arch Phys Med Rehabil 1998, 9:863–872.CrossRefGoogle Scholar
  2. 2.
    Simons DG, Travell JG, Simons LS: Travell & Simons’s Myofascial Pain and Dysfunction: the Trigger Point Manual, vol 1, edn 2. Baltimore: Williams & Wilkins; 1999.Google Scholar
  3. 3.
    Hong CZ: Myofascial trigger points: pathophysiology and correlation with acupuncture points. Acupunct Med 2000, 18:41–47.CrossRefGoogle Scholar
  4. 4.
    Hong CZ: New trends in myofascial pain syndrome (invited review). Chin Med J (Taipei) 2002, 65:501–512.Google Scholar
  5. 5.
    Fricton JR, Auvinen MD, Dykstra D, Schiffman E: Myofascial pain syndrome: electromyographic changes associated with local twitch response. Arch Phys Med Rehabil 1985, 66:314–317.PubMedGoogle Scholar
  6. 6.
    Chu J: Dry needling (intramuscular stimulation) in myofascial pain related to lumbar radiculopathy. Eur J Phys Med Rehabil 1995, 5:106–121.Google Scholar
  7. 7.
    Hong CZ: Consideration and recommendation of myofascial trigger point injection. J Musculoskel Pain 1994, 2:29–59.CrossRefGoogle Scholar
  8. 8.
    Hong CZ: Lidocaine injection versus dry needling to myofascial trigger point: the importance of the local twitch response. Am J Phys Med Rehabil 1994, 73:256–263.PubMedCrossRefGoogle Scholar
  9. 9.
    Gunn CC, Milbrandt WE, Little AS, Mason KE: Dry needling of motor points for chronic low-back pain: a randomized clinical trial with long-term follow-up. Spine 1980, 5:279–291.PubMedCrossRefGoogle Scholar
  10. 10.
    Simons DG: Diagnostic criteria of myofascial pain caused by trigger points. J Musculoskel Pain 1999, 7:111–120.CrossRefGoogle Scholar
  11. 11.
    Simons DG: Do endplate noise and spikes arise from normal motor endplates? Am J Phys Med Rehabil 2001, 80:134–140. This article discusses the correlation of endplate noise and MTrP.PubMedCrossRefGoogle Scholar
  12. 12.
    Kuan TS, Chang YC, Hong CZ: Distribution of active loci in rat skeletal muscle. J Musculoskel Pain 1999, 7:45–54.CrossRefGoogle Scholar
  13. 13.
    Simons DG, Hong CZ, Simons LS: Prevalence of spontaneous electrical activity at trigger spots and at control sites in rabbit skeletal muscle. J Musculoskel Pain 1995, 3:35–48.CrossRefGoogle Scholar
  14. 14.
    Simons DG, Hong CZ, Simons LS: Endplate potentials are common to midfiber myofascial trigger points. Am J Phys Med Rehabil 2002, 81:212–222. This study demonstrated the high prevalence of endplate noise in the trigger point region.PubMedCrossRefGoogle Scholar
  15. 15.
    Gerwin R, Simons D, Pongratz D: Neure ergebnisse zur pathogeneses myofaszialer schmerzsyndrome. Nervenheilkunde 2002, 21:35–37.Google Scholar
  16. 16.
    Hong CZ: Myofascial pain therapy. J Musculoskel Pain 2004, 12:37–43. This is the most recent review article that describes myofascial pain therapy.CrossRefGoogle Scholar
  17. 17.
    Bajaj P, Bajaj P, Graven-Nielsen T, Arendt-Nielsen L: Trigger points in patients with lower limb osteoarthritis. J Musculoskel Pain 2001, 9:17–33.CrossRefGoogle Scholar
  18. 18.
    Hsueh TC, Yu S, Kuan TS, Hong C-Z: Association of active myofascial trigger points and cervical disc lesion. J Formos Med Assoc 1998, 97:174–180.PubMedGoogle Scholar
  19. 19.
    Bogduk N, Simons DG: Progress in fibromyalgia and myofascial pain. Neck pain: joint pain or trigger points? In Pain Research and Clinical Management, vol 6. Edited by Vaeroy H, Mersky H. Amsterdam: Elsevier; 1993:267–273.Google Scholar
  20. 20.
    Hsieh CY, Hong CZ: Effect of chiropractic manipulation on the pain threshold of myofascial trigger point. In Proceedings of the 1990 International Conference of Spinal Manipulation. Los Angeles: Los Angeles College of Chiropractic; 1990:359–363.Google Scholar
  21. 21.
    Lee PS, Lin P, Hsieh LF, Hong CZ: Facet injection to control the recurrent myofascial trigger points: a case report. J Rehab Med Assoc ROC 1998, 26:41–45.Google Scholar
  22. 22.
    Borg-Stein J, Simons DG: Myofascial pain. Arch Phys Med Rehabil 2002, 83(Suppl 1):S40-S47.PubMedCrossRefGoogle Scholar
  23. 23.
    Hong CZ: Specific sequential myofascial trigger point therapy in the treatment of a patient with myofascial pain syndrome associated with reflex sympathetic dystrophy. Australasian Chiropractic & Osteopathy 2000, 9:7–11.Google Scholar
  24. 24.
    Kostopoulos D, Rizopoulos K: The Manual of Trigger Point and Myofascial Therapy. Thorofare, NJ: SLACK Inc.; 2001. This is one of the most recent books of manual therapy on myofascial pain.Google Scholar
  25. 25.
    Kraft GH, Stanton DF, Mein EA: Manual medicine. Phys Med Rehabil Clin N Am 1996, 7:679–932.Google Scholar
  26. 26.
    Melzack R: Myofascial trigger points: relation to acupuncture and mechanism of pain. Arch Phys Med Rehabil 1981, 62:114–117.PubMedGoogle Scholar
  27. 27.
    Hong CZ, Chen YC, Pon CH, Yu J: Immediate effects of various physical medicine modalities on pain threshold of the active myofascial trigger points. J Musculoskel Pain 1993, 1:37–52.CrossRefGoogle Scholar
  28. 28.
    Hsieh CY, Adams AH, Tobis JS, et al.: Effectiveness of four treatments for subacute low back pain: a randomized clinical trial. Spine 2002, 27:1142–1148.PubMedCrossRefGoogle Scholar
  29. 29.
    Lewit K: Manipulative Therapy in Rehabilitation of the Locomotor System, edn 2. Oxford: Butterworth Heinemann; 1991.Google Scholar
  30. 30.
    Lewit K: Postisometric relaxation in combination with other methods of muscular facilitation and inhibition. Manual Med 1986, 2:101–104.Google Scholar
  31. 31.
    McCain GA, Bell DA, Mai FM, et al.: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988, 31:1135–1141.PubMedCrossRefGoogle Scholar
  32. 32.
    Howlett TA: Hormonal responses to exercise and training: a short review. Clin Endocrinol 1987, 26:723–742.Google Scholar
  33. 33.
    Hsueh TC, Cheng PT, Kuan TS, Hong CZ: The immediate effectiveness of electrical nerve stimulation on myofascial trigger points. Am J Phys Med Rehabil 1997, 76:471–476.PubMedCrossRefGoogle Scholar
  34. 34.
    Hou CR, Tsai LC, Cheng KF, et al.: Immediate effects of various physical therapeutic modalities on cervical myofascial pain and trigger point sensitivity. Arch Phys Med Rehabil 2002, 83:1406–1414.PubMedCrossRefGoogle Scholar
  35. 35.
    Tanrikut A, Özaras N, Kaptan HA, et al.: High voltage galvanic stimulation in myofascial pain syndrome. J Musculoskel Pain 2003, 11:11–15.CrossRefGoogle Scholar
  36. 36.
    Snyder-Mackler L, Bork C, Bourbon B, et al.: Effect of helium-neon laser on musculoskeletal trigger points. Phys Ther 1986, 66:1087–1090.PubMedGoogle Scholar
  37. 37.
    Kleinkort JA, Foley RA: Laser acupuncture: its use in physical therapy. Am J Acupunct 1984, 12:1251–1256.Google Scholar
  38. 38.
    Lewit K: The needle effect in relief of myofascial pain. Pain 1979, 6:83–90.PubMedCrossRefGoogle Scholar
  39. 39.
    Gunn CC: Treatment of Chronic Pain. Intramuscular Stimulation for Myofascial Pain of Radiculopathic Origin. London: Churchill Livingston; 1996.Google Scholar
  40. 40.
    Fischer AA: Treatment of myofascial pain. J Musculoskel Pain 1999, 7:131–142.CrossRefGoogle Scholar
  41. 41.
    Chu J, Yuen K, Wang B, et al.: Electrical twitch-obtaining intramuscular stimulation in lower back pain. Am J Phys Med Rehabil 2004, 83:104–111.PubMedCrossRefGoogle Scholar
  42. 42.
    Baldry PE: Superficial dry needling. In Fibromyalgia Syndrome: A Practitioner’s Guide to Treatment. Edited by Chaitow CL. Edinburgh: Churchill Livingston; 2000.Google Scholar
  43. 43.
    Goddard G, Karibe H, McNeill C, Vallafuerte E: Acupuncture and sham acupuncture reduce muscle pain in the myofascial pain patients. J Orofac Pain 2002, 16:71–76.PubMedGoogle Scholar
  44. 44.
    Cummings TM, White AR: Needling therapies in the management of myofascial trigger point pain: a systemic review. Arch Phys Med Rehabil 2001, 82:986–992. This article is a meta-analysis of different trials on the efficacy of needling therapies in the treatment of MTrP pain.PubMedCrossRefGoogle Scholar
  45. 45.
    Kuan TS, Chen JT, Chen SM, et al.: Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil 2002, 81:512–520. This study clarified the mechanism of treatment with botulinum toxin for myofascial pain.PubMedCrossRefGoogle Scholar
  46. 46.
    Cheshire WP, Abashian SW, Mann JD: Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994, 59:65–69.PubMedCrossRefGoogle Scholar
  47. 47.
    Wheeler AH, Goolkasian P, Gretz SS: A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 1998, 23:1662–1667.PubMedCrossRefGoogle Scholar
  48. 48.
    Graboski CL, Gray DS, Burnham RS: Botulism toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomized double blind cross over study. Pain 2005, 118:170–175.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Department of Physical TherapyHungkuang UniversityShaluTaiwan

Personalised recommendations